menu Search
Zuellig Pharma
Abbott

ALTHERA LABORATORIES LIMITED

Featured products of Althera Laboratories
Lypstaplus
Lypstaplus FC tab 10/10 mg
rosuvastatin, ezetimibe
Packing/Price
10's30's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10BA06 - rosuvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
Lypstaplus FC tab 20/10 mg
rosuvastatin, ezetimibe
Packing/Price
30's10's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10BA06 - rosuvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
Distributed by Zuellig Pharma
Lypstaplus
Lypstaplus FC tab 10/10 mg
rosuvastatin, ezetimibe
Packing/Price
10's30's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10BA06 - rosuvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
Lypstaplus FC tab 20/10 mg
rosuvastatin, ezetimibe
Packing/Price
30's10's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10BA06 - rosuvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
Marketed by Abbott
Lypstaplus
Lypstaplus FC tab 10/10 mg
rosuvastatin, ezetimibe
Packing/Price
10's30's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10BA06 - rosuvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
Lypstaplus FC tab 20/10 mg
rosuvastatin, ezetimibe
Packing/Price
30's10's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10BA06 - rosuvastatin and ezetimibe : Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.